MedTrace Logo

Influenza Vaccination and Oral Anticoagulant Therapy

NCT00222638 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2005-09-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate INR and INR related index and Warfarin weekly dosage variations after Influenza Vaccination

Conditions

  • Anticoagulants
  • Influenza Vaccines

Interventions

DRUG

Influenza vaccination

Sponsors & Collaborators

  • University Of Perugia

    lead OTHER

Principal Investigators

  • Alfonso Iorio · University Of Perugia

  • Maria Vecchioli · Regional Sanitary Agency (ASL2-Perugia)

  • Anna Maria Iorio · Institute of Virology - University of Perugia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2005-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00222638 on ClinicalTrials.gov